Pegfilgrastim Safely Administered on the Same Day as Dose-dense Chemotherapy for Patients with Advanced-stage Ovarian Carcinoma von Micha, J.P, Brown, J.V, Rettenmaier, M.A, Abaid, L.N, Mendivil, A.A, Lopez, K.L, Goldstein, B.H

Volltext

837P Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) von Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Stephens, A.J., Ahmad, S.

Volltext

Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) von Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M.M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Smith, J.L., Stephens, A.J., Ahmad, S.

Volltext